[Vaccination of children against hepatitis B in Mayotte, French Comoros Island].
Hepatitis B virus (HBV) is responsible for a worldwide mortality of 1 million people each year. It constitutes a major public health problem, especially in highly endemic zones, where it concerns the youngest children, primarily by a mother to child transmission, with a strong risk of chronic hepatitis infection and hepatocellular carcinoma. Immunisation of children versus HBV is known to be efficient and safe. In Mayotte, a French overseas territory in Indian Ocean, immunisation versus HBV has been introduced since 1993 in the vaccine schedule, starting at day 1 of life. We report hereby the local experience and practice on HBV infection, state of vaccine coverage, and difficulties met with this major public health issue.
Muszlak
M
M
Service de pédiatrie et néonatologie, centre hospitalier de Mayotte, Mamoudzou, Mayotte, France. m.muszlak@chmayotte.fr
Lartigau-Roussin
C
C
Farthouat
L
L
Petinelli
M
M
Hebert
J-C
JC
Santiago
J
J
D000328:Adult; D002985:Clinical Protocols; D017507:Comoros / Q000453:epidemiology; D018562:Disease Transmission, Infectious; D005260:Female; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission; D017325:Hepatitis B Vaccines; D019694:Hepatitis B, Chronic / Q000453:epidemiology; D006801:Humans; D007115:Immunization Schedule; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D011247:Pregnancy; D014611:Vaccination / Q000706:statistics & numerical data
D017325:Hepatitis B Vaccines